Medtronic Cardiovascular Chief Coyle To Lead iRhythm

Sean Salmon, the head of Medtronic’s diabetes business, will take over the leadership of the company’s cardiovascular business effective 1 January.

Vector illustration; business leadership concept
• Source: shutterstock.com

Michael Coyle, the president of Medtronic’s cardiovascular business, is leaving the company to become the CEO of digital health company iRhythm at the end of December.

Sean Salmon, currently the president of Medtronic’s diabetes business will become president of Medtronic’s cardiovascular business, effective 1 January, while...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Leadership

More from Medtech Insight